Tech Company Financing Transactions

Kymera Therapeutics Funding Round

Kymera Therapeutics closed a $65 million Series B funding round on 11/14/2018. Investors included 6 Dimensions Capital, Bessemer Venture Partners and Pfizer Venture Investments.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

300 Technology Sq. 2nd Floor
Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.kymeratx.com

Email Address

[email protected]

Overview

Kymera Therapeutics (Nasdaq: KYMR). Despite recent advances in modern medicine, hundreds of millions of people are affected by acute and chronic diseases with limited or no available treatment options. Kymera is pioneering a game-changing new therapeutic modality with the potential to transform drug discovery and provide breakthrough treatments for previously untreatable diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Nello Mainolfi

        

Chief Financial Officer

Bruce Jacobs

        

Chief Medical Officer

Jared Gollob

        

Browse more venture capital transactions:

Prev: 11/14/2018: Heyday Online venture capital transaction
Next: 11/14/2018: SecureSet Academy venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary